Max Bayer – Page 12 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

GSK wins second Zantac cancer case to go to trial

10 months ago

BioCryst culls Factor D inhibitor; Elevation Oncology’s stock plummets

10 months ago

Nuvation pauses BET inhibitor plans after checking out interim Phase 1 data

10 months ago

Bristol Myers to cut more jobs at headquarters as part of announced restructure

10 months ago

Q&A: Genentech's new CEO on AI, IRA and radiopharma

10 months ago

Vir's overhaul brings an end to most virology work — and a beginning with cancer

10 months ago

Despite recent trial success, uniQure plans to cut 65% of staff

10 months ago

Arbutus reduces headcount after axing HBV combo trial that features Imfinzi

10 months ago

It took more than two decades for MDMA to reach the FDA. In two months, its prospects cracked. What happens next?

10 months ago

Sanofi sues Sarepta, alleging that Duchenne treatment Elevidys infringes on AAV patents

10 months ago

Biosecure lawmakers tell trade groups that China studies are a new focus

10 months ago

China corruption crackdown hits Merck’s Gardasil sales, spooking investors

10 months ago

Keytruda tops $7B quarterly sales for the first time

10 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

10 months ago

Among pharma CEOs, the IRA now and the IRA later get very different reactions

10 months ago

EU panel follows FDA’s lead on Wegovy, recommending use to prevent cardiac events

11 months ago

Sanofi shelves four assets, including mid-stage dwarfism candidate

11 months ago

BioMarin snags expanded Brineura label, now approved for all kids regardless of symptoms

11 months ago

US bankrolls a third of global Pandemic Fund. Can it get congressional support?

11 months ago

Novartis pays $150M upfront, including $25M in equity, for Dren Bio’s bispecifics

11 months ago

Updated: Merck, without sharing details, says RSV antibody successfully protected infants

11 months ago

Chinese biotech boasts competitive Phase 2b weight loss data for GLP-1 drug

11 months ago

Vermont attorney general sues two major PBMs for allegedly driving up costs

11 months ago

US inks $113M deal with Siga to bolster smallpox, mpox reserves

11 months ago

First page Previous page 9 10 111213 14 Next page Last page